A detailed history of Saratoga Research & Investment Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Saratoga Research & Investment Management holds 708,519 shares of NVO stock, worth $61.9 Million. This represents 3.69% of its overall portfolio holdings.

Number of Shares
708,519
Previous 748,717 5.37%
Holding current value
$61.9 Million
Previous $107 Million 21.06%
% of portfolio
3.69%
Previous 4.86%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

SELL
$119.07 - $145.42 $4.79 Million - $5.85 Million
-40,198 Reduced 5.37%
708,519 $84.4 Million
Q2 2024

Aug 16, 2024

SELL
$122.71 - $146.91 $4.3 Million - $5.15 Million
-35,074 Reduced 4.47%
748,717 $107 Million
Q1 2024

Apr 17, 2024

SELL
$102.11 - $135.92 $4.47 Million - $5.95 Million
-43,803 Reduced 5.29%
783,791 $101 Million
Q4 2023

Feb 09, 2024

SELL
$87.78 - $105.45 $5.49 Million - $6.6 Million
-62,571 Reduced 7.03%
827,594 $85.6 Million
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $39.3 Million - $86.3 Million
432,473 Added 94.49%
890,165 $81 Million
Q2 2023

Jul 24, 2023

SELL
$155.98 - $172.65 $1.82 Million - $2.02 Million
-11,682 Reduced 2.49%
457,692 $74.1 Million
Q1 2023

May 05, 2023

SELL
$132.34 - $159.14 $27.7 Million - $33.3 Million
-208,963 Reduced 30.81%
469,374 $74.7 Million
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $2.11 Million - $2.78 Million
-20,572 Reduced 2.94%
678,337 $91.8 Million
Q3 2022

Oct 31, 2022

SELL
$95.28 - $116.93 $761,001 - $933,919
-7,987 Reduced 1.13%
698,909 $69.6 Million
Q2 2022

Aug 01, 2022

SELL
$103.24 - $121.81 $8.2 Million - $9.67 Million
-79,400 Reduced 10.1%
706,896 $78.8 Million
Q1 2022

Apr 29, 2022

SELL
$93.1 - $112.54 $1.13 Million - $1.37 Million
-12,158 Reduced 1.52%
786,296 $87.3 Million
Q4 2021

Feb 08, 2022

SELL
$95.88 - $117.08 $3.52 Million - $4.3 Million
-36,724 Reduced 4.4%
798,454 $89.4 Million
Q3 2021

Nov 05, 2021

SELL
$84.42 - $106.62 $34 Million - $42.9 Million
-402,733 Reduced 32.53%
835,178 $80.2 Million
Q2 2021

Aug 10, 2021

BUY
$67.66 - $84.76 $1.05 Million - $1.31 Million
15,487 Added 1.27%
1,237,911 $104 Million
Q1 2021

Apr 12, 2021

BUY
$67.06 - $75.82 $3.67 Million - $4.15 Million
54,727 Added 4.69%
1,222,424 $82.4 Million
Q4 2020

Feb 03, 2021

BUY
$63.89 - $73.8 $1.58 Million - $1.82 Million
24,675 Added 2.16%
1,167,697 $81.6 Million
Q3 2020

Oct 09, 2020

SELL
$63.69 - $70.22 $2.8 Million - $3.09 Million
-44,006 Reduced 3.71%
1,143,022 $79.4 Million
Q2 2020

Aug 07, 2020

SELL
$58.54 - $67.94 $19.5 Million - $22.7 Million
-333,722 Reduced 21.94%
1,187,028 $77.7 Million
Q1 2020

May 13, 2020

SELL
$49.46 - $64.78 $569,432 - $745,812
-11,513 Reduced 0.75%
1,520,750 $91.5 Million
Q4 2019

Feb 05, 2020

SELL
$49.86 - $58.26 $669,968 - $782,839
-13,437 Reduced 0.87%
1,532,263 $88.7 Million
Q3 2019

Oct 29, 2019

SELL
$47.54 - $53.43 $179,178 - $201,377
-3,769 Reduced 0.24%
1,545,700 $79.9 Million
Q2 2019

Jul 24, 2019

BUY
$46.79 - $52.47 $1.83 Million - $2.05 Million
39,123 Added 2.59%
1,549,469 $79.1 Million
Q1 2019

Apr 18, 2019

BUY
$46.36 - $52.63 $3.39 Million - $3.84 Million
73,054 Added 5.08%
1,510,346 $79 Million
Q4 2018

Jan 15, 2019

SELL
$41.54 - $47.25 $2.15 Million - $2.44 Million
-51,725 Reduced 3.47%
1,437,292 $66.2 Million
Q3 2018

Oct 15, 2018

SELL
$46.76 - $51.24 $1.52 Million - $1.67 Million
-32,579 Reduced 2.14%
1,489,017 $70.2 Million
Q2 2018

Jul 17, 2018

SELL
$44.29 - $50.42 $1.2 Million - $1.37 Million
-27,083 Reduced 1.75%
1,521,596 $70.2 Million
Q1 2018

May 01, 2018

BUY
$48.49 - $58.14 $1.86 Million - $2.23 Million
38,323 Added 2.54%
1,548,679 $76.3 Million
Q4 2017

Jan 19, 2018

BUY
$47.53 - $53.73 $703,444 - $795,204
14,800 Added 0.99%
1,510,356 $81.1 Million
Q3 2017

Oct 24, 2017

BUY
$41.15 - $49.22 $61.5 Million - $73.6 Million
1,495,556
1,495,556 $72 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Saratoga Research & Investment Management Portfolio

Follow Saratoga Research & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saratoga Research & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Saratoga Research & Investment Management with notifications on news.